Cipla informs about updates

19 Dec 2025 Evaluate

Cipla has informed that Cipla has entered into an exclusive Supply and Marketing Agreement with Pfizer Products India and Pfizer (hereinafter together referred as Pfizer) for marketing and distribution of four brands of Pfizer, Corex, Dolonex, Neksium and Dalacin C for a period of 5 years. The additional details required to be disclosed, pursuant to the Listing Regulations read with the SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, are enclosed as Annexure A. A joint press release issued by Pfizer and Cipla in this regard in enclosed as Annexure B. This intimation is being made to the stock exchanges as part of its commitment to good corporate governance practices.

The above information is a part of company’s filings submitted to BSE.

Cipla Share Price

1517.00 17.90 (1.19%)
19-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1745.10
Dr. Reddys Lab 1278.90
Cipla 1517.00
Zydus Lifesciences 919.85
Lupin 2125.70
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×